| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fadc18369dac6778fe6217aed49ada7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate |
2008-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2929ca1591ebae2aedf112d791247c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e5a82944a6956acfc27c69d3fb3aa6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01312fadfc0a6545b3e0b62083f46944
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d684422ffa549555809e3cbe5ef924
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84a710b3a65e805e236bd3ee3de3aea4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04f7379f0b2b7ae5ee81d46cd8ee7f2e |
| publicationDate |
2010-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101720324-A |
| titleOfInvention |
[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazoline-3-yl)-phenyl]-5-chloro-thiophene-2-base-sulfonylurea salt, its relevant form and method |
| abstract |
The invention provides the new sulfonylurea salt and the polymorphic form form thereof of the salt of formula (I).Various forms of described compounds are effective platelet ADP receptor inhibitors, and can be used for various pharmaceutical compositions, and effective especially to preventing and/or treating cardiovascular disorder, particularly thrombosis relative disease.The present invention also provides and has been used to the method for preparing the method for described compound and form and be used for preventing or treat Mammals thrombosis and thrombosis associated conditions, and it comprises the salt of formula (I) of administering therapeutic significant quantity or the step of its pharmaceutically acceptable form. |
| priorityDate |
2007-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |